About Index Trending news
Lists
Pricing
Ablynx

Ablynx

Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® for a range of serious human diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

30 Oct 2017
$230,000,000
Post-IPO equity
13 Aug 2014
$2,808,275
Grant
30 Jun 2014
$56,972,661
Post-IPO equity